TY - JOUR
T1 - Current status of research on cognitive therapy/cognitive behavior therapy in Japan
AU - Ono, Yutaka
AU - Furukawa, Toshi A.
AU - Shimizu, Eiji
AU - Okamoto, Yasumasa
AU - Nakagawa, Akiko
AU - Fujisawa, Daisuke
AU - Nakagawa, Atsuo
AU - Ishii, Tomoko
AU - Nakajima, Satomi
PY - 2011/3
Y1 - 2011/3
N2 - Cognitive therapy/cognitive behavior therapy was introduced into the field of psychiatry in the late 1980s in Japan, and the Japanese Association for Cognitive Therapy (JACT), founded in 2004, now has more than 1500 members. Along with such progress, awareness of the effectiveness of cognitive therapy/cognitive behavioral therapy has spread, not only among professionals and academics but also to the public. The Study Group of the Procedures and Effectiveness of Psychotherapy, funded by the Ministry of Health, Labor and Welfare, has conducted a series of studies on the effectiveness of cognitive therapy/cognitive behavior therapy since 2006 and shown that it is feasible for Japanese patients. As a result, in April 2010 cognitive therapy/cognitive behavior therapy for mood disorders was added to the national health insurance scheme in Japan. This marked a milestone in Japan's psychiatric care, where pharmacotherapy has historically been more common. In this article the authors review research on cognitive therapy/cognitive behavior therapy in Japan.
AB - Cognitive therapy/cognitive behavior therapy was introduced into the field of psychiatry in the late 1980s in Japan, and the Japanese Association for Cognitive Therapy (JACT), founded in 2004, now has more than 1500 members. Along with such progress, awareness of the effectiveness of cognitive therapy/cognitive behavioral therapy has spread, not only among professionals and academics but also to the public. The Study Group of the Procedures and Effectiveness of Psychotherapy, funded by the Ministry of Health, Labor and Welfare, has conducted a series of studies on the effectiveness of cognitive therapy/cognitive behavior therapy since 2006 and shown that it is feasible for Japanese patients. As a result, in April 2010 cognitive therapy/cognitive behavior therapy for mood disorders was added to the national health insurance scheme in Japan. This marked a milestone in Japan's psychiatric care, where pharmacotherapy has historically been more common. In this article the authors review research on cognitive therapy/cognitive behavior therapy in Japan.
KW - Japan
KW - cognitive behavior therapy
KW - cognitive therapy
KW - effectiveness
UR - http://www.scopus.com/inward/record.url?scp=79952962434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952962434&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1819.2010.02182.x
DO - 10.1111/j.1440-1819.2010.02182.x
M3 - Review article
C2 - 21414087
AN - SCOPUS:79952962434
SN - 1323-1316
VL - 65
SP - 121
EP - 129
JO - Psychiatry and Clinical Neurosciences
JF - Psychiatry and Clinical Neurosciences
IS - 2
ER -
